← Back to Search

Crosslinking

Crosslinking using UV light of two different fluence rates for Keratoconus

N/A
Recruiting
Led By Gregory Kent, MD
Research Sponsored by McNeel Eye Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Males or females between the ages of 15 and 50 with keratoconus diagnosed topographically with or without other corneal ectatic disease.
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights

Study Summary

This trial will study whether a different fluence rate and treatment time for corneal crosslinking is effective in treating keratoconus, pellucid marginal degeneration, and post-LASIK iatrogenic ectasia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post treatment topographic analysis of Crosslinked patients
Secondary outcome measures
Post Treatment Best Corrected Visual Acuity

Trial Design

1Treatment groups
Experimental Treatment
Group I: Crosslinking at different fluence ratesExperimental Treatment1 Intervention
The study will investigate the effectiveness of Transepithelial riboflavin .25% treated with Ultraviolet light at fluence rates of 9mw/cm2 and 18mw/cm2 in the treatment of diagnosed keratoconus, pellucid marginal degeneration or post-LASIK ectasia.

Find a Location

Who is running the clinical trial?

McNeel Eye CenterLead Sponsor
Gregory Kent, MDPrincipal InvestigatorThe Eye Associates
Brian J McNeel, ODStudy DirectorMcNeel Eye Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Utah
How old are they?
18 - 65
What site did they apply to?
McNeel Eye Center
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
Recent research and studies
clinicaltrials.govStudy
McNeel Eye Center Corneal Crosslinking Study
Brian J. McNeel 2016. "McNeel Eye Center Corneal Crosslinking Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02921009.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top